SOURCES SOUGHT
R -- Management and Operation of a High Containment NIAID Integrated Research Facility (IRF) at Fort Detrick
- Notice Date
- 5/10/2016
- Notice Type
- Sources Sought
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 5601 Fishers Lane, 3rd Floor MSC 9822, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- DHHS-NIH-NIAID(OA)-SBSS-2016-038
- Archive Date
- 10/31/2017
- Point of Contact
- LaDonna R Stewart, Phone: 240-669-5123
- E-Mail Address
-
lstewart@niaid.nih.gov
(lstewart@niaid.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Introduction This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. This requirement is assigned a code of 541711 in the North American Industry Classification System (NAICS), and the small business size standard for such requirements is 1,000 Employees. Background The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID has a unique mandate, which requires the Institute to respond to emerging public health threats. Toward this end, NIAID manages a complex and diverse research portfolio that aims to do the following: •• Expand the breadth and depth of knowledge in all areas of infectious, immunologic, and allergic diseases •• Develop flexible domestic and international research capabilities to appropriately respond to emerging and re- emerging disease threats at home and abroad The NIAID research portfolio has expanded in response to challenges including bio-terrorism and emerging and re-emerging infectious diseases for greater than a decade. NIAID is actively engaged in the clinical research networks world-wide including clinical trials and emergency responses to outbreaks. Research initiatives to mitigate the threat of bioterrorism as well as emerging infectious diseases associated with high consequence pathogens include Viral Hemorrhagic Fevers including Ebola, Marburg, Lassa, and Nipah viruses as well as coronaviruses including MERS-CoV and influenza. Characterization of newly emerging infectious disease agents associated with fevers of unknown origin is also priority. Purpose and Objectives NIAID supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of the world's most infectious and wide-spread immune-mediated diseases. Key research areas include newly emerging and re-emerging infectious diseases such as tuberculosis and influenza, HIV/AIDS, biodefense, and immune-mediated diseases including asthma and allergy. Project requirements The NIAID IRF is part of the National Interagency Biodefense Campus based at Fort Detrick, Maryland with the primary focus to manage, coordinate and facilitate the conduct of research with emerging infectious diseases and biodefense pathogens to develop countermeasures, improved medical outcomes for patients and control strategies for human health. The NIAID IRF is a specialized biocontainment facility with the appropriate infrastructure to support basic research and animal studies with various infectious disease agents including those requiring the highest level of biocontainment, (BSL-4) to evaluate therapeutics, vaccines and diagnostics as well as natural history and pathogenesis associated with these agents. The IRF is comprised primarily of biosafety (BSL) 4 areas connected to biosafety (BSL) 2 support labs and administrative space. The IRF does not have BSL-3 labs per se, but zones within the BSL-4 area can be operated at BSL-3 level, if necessary. The BSL-4 area at the IRF includes both Class III cabinets and spacesuit laboratories including an aerobiology exposure suite (with Class III cabinets); the BSL-4 area also includes 8 non-human primate (NHP) holding rooms and 2 small animal (mice, rabbits, and guinea pigs) holding rooms. The high-containment area of the building houses a clinical pathology laboratory as well as medical imaging equipment analogous to that found in a hospital. The purpose for this capability is to facilitate research with refined animal models for biodefense agents as well as to test human samples associated with naturally occurring outbreaks in the high containment environment. The 146,000 GSF of the IRF is comprised of the following: 9,451 net sq. ft. BSL2 14,047 net sq. ft. BSL4 12,067 net sq. ft. administrative & other space 110,435 net sq. ft. Corridors, mechanical spaces, and conference rooms Scope Except where provided by NIH/NIAID, the Contractor will be responsible for all staffing; equipment, material, and supply purchases; establishing and maintaining service agreements as necessary; and providing all other supporting functions necessary for efficient management and operation of the NIAID IRF 24 hours a day, 365 days a year. Day-to-day operations of the IRF function in three distinct categories: • Scientific Services - Scientific, operational and programmatic services necessary to ensure the IRF meets its research objectives, including imaging services. This effort includes work within a biosafety level 4 (BSL-4) environment. • Animal Care & Technical Services - Technical services required for the proper care, use and humane treatment of laboratory animals and a wide range of technical skills required for the scientific study and manipulation of animals exposed to infectious agents • Administrative Services - Administrative services necessary to ensure that all facets of the IRF function effectively and efficiently The IRF requires support services to facilitate: •· Biosafety level (BSL) Scientific/Laboratory operations at BSL- 2 through BSL-4 inclusive of: •o Clinical Core Services of Molecular Biology, Immunology, Virology, Cell Culture •o Aerobiology •o Pathology •o Imaging Physics with emphasis on Magnetic Resonance Imaging (MRI), Computed tomography (CT); Single Positron Emission Computed Tomography (SPECT); Positron Emission Tomography (PET) and Ultrasonography •· Outbreak Laboratory Support deployment to international and domestic sites •· Comparative Medicine and Animal Care and Technical Support at IRF •· Administrative Management and Operations inclusive of: •o Training •o Programmatic and Logistical Support Scientists at the IRF focus intensively on developing prevention and treatment options that will be directly relevant to naturally occurring or deliberately introduced human diseases. At present there are one hundred and five (105) FT contract positions including those added to support the increased research capacity Ebola survivor surveillance in West Africa. These numbers may increase in the future. The anticipated distribution of contractor labor is as follows: Leadership: (2 total) Operations Director (1 FTE) Scientific Lead/Investigator (1 FTE) Scientific: (60 total) Associate Science Supervisor/Study Implementer (1 FTE) High Containment Supervisor/Study Implementer (1 FTE) High Containment Technician (1 FTE) Study Implementers (3 FTEs) Associate Study Implementers (5 FTEs) Support Scientists (16 FTEs) Outbreak Response Coordinator (1 FTE) Outbreak Response Scientists (6 FTEs) Clinical Lab Services Coordinator (1 FTE) Core Services Lead (1 FTE) Core Service Technicians (8 FTEs) Cell Culture Lead (1 FTE) Cell Culture Technicians (2 FTEs) Core Services Immunology Lead (1 FTE) Core Services Immunology Technician (1 FTE) Core Services Molecular Lead (1 FTE) Lead Virologist (1 FTE) Electron Microscopist (1 FTE) Aerobiologist (1 FTE) Aerobiology Technician (1 FTE) Viral Repository Manager (1 FTE) Science Data Management Lead (1 FTE) Science Data Coordinator (1 FTE) Medical Illustrator (1 FTE) Biomedical Equipment/Property Maintenance Technician (1 FTE) Biomedical Equipment Maintenance Technician (1 FTE) Imaging Services: (5 total) Director of Imaging Sciences (1 FTE) Imaging Lead (1 FTE) Junior Physicist (1 FTE) Imaging Physicist Support (1 FTE) Imaging Technologist (1 FTE) Animal Care: (20 total) Veterinary Program Manager (1 FTE) Animal Facility Manager (1FTE) Research Support Specialists (4 FTEs) Laboratory Animal Technicians (7 FTEs) Animal Caretakers (5 FTEs) Animal Caretaker/Cage Wash Supervisor (1 FTE) Animal Care Administrator (1 FTE) Gross and Anatomical Pathology: (9 total) Pathology Lead (1 FTE) Research Pathologists (3 FTEs) Pathology Support Specialists (2 FTEs) Histology Lab Manager (1 FTE) Histology Technicians (2 FTEs) Administrative: (9 total) Project Manager/Financial Analyst (1 FTE) Project Management Assistant (1 FTE) Executive Assistant/Travel Coordinator (1 FTE) Technical/Research Writer (1 FTE) Procurement Administrators (3 FTEs) Loading Dock Manager (1 FTE) Loading Dock Technician (1 FTE) Anticipated period of performance The anticipated period of performance of any contract resulting from a solicitation and negotiated award will be for a total of seven (7) years. The base period will be for 24 months, with the potential for the Government to exercise up to five (5), 12 month optional periods. Other important considerations IRF Staff may be required at times to deploy to infectious disease outbreak sites in support of NIAID DCR clinical protocols around the world (e.g. inclusive of but not limited to the USA, West Africa, Southeast Asia, South America, etc.). Legislative mandates for support of these efforts may originate from the U.S. Congress, U. S. State Department, Department of Defense, DHHS, NIH or NIAID. Capability statement / information sought Interested qualified small business organizations should submit one electronic, tailored Capability Statement not to exceed seven (7) pages, excluding resumes. Respondents should not include resumes at this time but should synopsize: (a) key personnel education and experience and availability; (b) current in-house capability and capacity to perform the work; (c) prior completed projects of similar nature; (d) corporate experience and management capability; and (e) examples of prior completed Government contracts, references, (f) teaming agreements or other related information which can be used to evaluate the respondent's capacity to perform the work as noted above. Capability Statements must not include links to internet web site addresses (URLs) or otherwise direct readers to alternate sources of information. Font size must be 10 to 12 points. Spacing must be no more than 15 characters per inch. Within a vertical inch, there must be no more than six lines of text. Print margins must be at least one-inch on each edge of the paper. Print setup should be single-sided on standard letter size paper (8.5 x 11" in the U.S., A4 in Europe). All proprietary information should be marked as such. Respondents should also include the following on the inside of the cover or within the 1 st page of their capability statement: business type, size and small business status of the organization pursuant to the applicable NAICS code (541711) as validated via the System for Award Management (SAM) located at https://www.sam.gov/index.html/#1 ; DUNS number; and points of contact (POC's), including names, titles, addresses, telephone numbers, and email addresses. All inquiries and Capability Statements sent in response to this Small Business Sources Sought notice must be submitted electronically (via e-mail) to LaDonna Stewart, Contract Specialist at lstewart@niaid.nih.gov no later than 12:00pm EST, May 24, 2016. Capability statements must be submitted in MS Word or Adobe Portable Document Format (PDF). The e-mail subject line must specify the Sources Sought Reference Number: DHHS-NIH-SBSS- NIAID(AO)-2016-038. Facsimile responses will not be accepted. CAPABILITY STATEMENTS RECEIVED AFTER THIS DATE AND TIME WILL NOT BE CONSIDERED. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/AMOB/DHHS-NIH-NIAID(OA)-SBSS-2016-038/listing.html)
- Place of Performance
- Address: Fort Detrick, Frederick, Maryland, United States
- Record
- SN04112580-W 20160512/160510235351-6b918f72e61c7d4feae9af76ef28292e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |